Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Non-cash Items (2016 - 2025)

Traws Pharma (TRAW) has disclosed Non-cash Items for 13 consecutive years, with $407646.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items rose 61.12% to $407646.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $407646.0, a 61.12% increase, with the full-year FY2024 number at $2.7 million, up 12747.62% from a year prior.
  • Non-cash Items was $407646.0 for Q3 2025 at Traws Pharma, up from $25000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $2.7 million in Q4 2024 to a low of $8362.5 in Q1 2022.
  • A 5-year average of $583325.7 and a median of $253000.0 in 2024 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: soared 12747.62% in 2024, then plummeted 97.79% in 2025.
  • Traws Pharma's Non-cash Items stood at $233000.0 in 2021, then dropped by 0.22% to $232488.0 in 2022, then tumbled by 90.97% to $21000.0 in 2023, then skyrocketed by 12747.62% to $2.7 million in 2024, then crashed by 84.89% to $407646.0 in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Non-cash Items are $407646.0 (Q3 2025), $25000.0 (Q2 2025), and $406320.0 (Q1 2025).